HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Sook-Whan Sung Chang Hyun Kang Young Tae Kim Sung Koo Han Joo Hyun Kim Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sung, S.-W. Articles by Kim, J. H. Search for Related Content PubMed PubMed Citation Articles by Sung, S.-W. Articles by Kim, J. H.

Eur J Cardiothorac Surg 1999;16:187-193
© 1999 Elsevier Science NL

Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis

^a Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, 28 Yongon, Chongno, Seoul, 110-744, South Korea
^b Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

Corresponding author. Tel.: +82-2-7603637; fax: +82-2-7643664
e-mail: swsung{at}snu.ac.kr,

Background: Medical treatment of multiple drug resistant (MDR) pulmonary tuberculosis is generally quite unsuccessful. Recently, surgical management is increasing and shows promise. We analyzed our experience to identify the benefits and complications of pulmonary resection in MDR pulmonary tuberculosis. Methods: A retrospective review was performed in 27 patients undergoing pulmonary resection for MDR pulmonary tuberculosis between January 1994 and March 1998. Their average ages were 40 years and were diagnosed a median of 15 months before surgery. All patients had resistance to an average of 4.4 drugs including isoniazid and rifampin, and had received second line drugs selected according to drug sensitivity test preoperatively. Most patients (92.6%) had cavitary lesions. Bilateral lesions were also identified in 19 patients (70.4%), but the main focus was recognized in one side of the lung. Most patients were indicated to operation for those who could not achieve negative sputum despite adequate medical treatment (n=16, 59.3%); or for negative patients who had significant pulmonary parenchymal lesion (n=11, 40.7%) which would have had a high probability of recurrence. Pneumonectomy was done in nine patients, lobectomy in 16 and segmentectomy in two. Results: There was no operative mortality. Morbidity occurred in seven patients (25.9%); prolonged air leakage in three patients, reoperation due to bleeding in two, bronchopleural fistula in one, and reversible blindness in one. The median follow up period was 15 months (range 3–45). Sputum negative conversion was achieved in 22 patients (81.5%) initially. However, continued postoperative chemotherapy could convert to negative in another four patients (14.8%). Only one pneumonectomy patient (3.7%) failed because of considerable contralateral cavity. Conclusion: For patients with MDR pulmonary tuberculosis which is localized, and with adequate pulmonary reserve function, surgical pulmonary resection combined with appropriate pre and postoperative anti-tuberculosis chemotherapy can achieve high success rate with acceptable morbidity.

Key Words: Multi-drug resistant • Tuberculosis • Lung • Surgery

This article has been cited by other articles:

				T. Mohsen, A. Abou Zeid, and S. Haj-Yahia Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 194 - 198. [Abstract] [Full Text] [PDF]

				L P. Ormerod Role of surgery in pulmonary multidrug-resistant tuberculosis Thorax, May 1, 2007; 62(5): 377 - 377. [Full Text] [PDF]

				J. G Somocurcio, A. Sotomayor, S. Shin, S. Portilla, M. Valcarcel, D. Guerra, and J. Furin Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Thorax, May 1, 2007; 62(5): 416 - 421. [Abstract] [Full Text] [PDF]

				R. Naidoo Active Pulmonary Tuberculosis: Experience with Resection in 106 Cases Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 134 - 138. [Abstract] [Full Text] [PDF]

				A. Olcmen, M. Z Gunluoglu, A. Demir, H. Akin, H. V Kara, and S. I Dincer Role and Outcome of Surgery for Pulmonary Tuberculosis Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 363 - 366. [Abstract] [Full Text] [PDF]

				H. J. Kim, C. H. Kang, Y. T. Kim, S-W. Sung, J. H. Kim, S. M. Lee, C-G. Yoo, C-T. Lee, Y. W. Kim, S. K. Han, et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis Eur. Respir. J., September 1, 2006; 28(3): 576 - 580. [Abstract] [Full Text] [PDF]

				Adjuvant resectional surgery improves cure rates in multidrug-resistant tuberculosis. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 693 - 696.

				Y. Shiraishi, Y. Nakajima, N. Katsuragi, M. Kurai, and N. Takahashi Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 523 - 528. [Abstract] [Full Text] [PDF]